Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss ...

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

PEMBROKE PARK, Fla. – Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...